Elevated concentrations of interleukins and leukotriene in response to mycobacterium tuberculosis infection

Annals of Clinical Biochemistry

Volumn 34, Issue 2, 1997, Pages 160-164

  El Ahmady, O ^a,b   Mansour, M ^a   Zoeir, H ^a   Mansour, O ^a  

^a AL AZHAR UNIVERSITY   (Egypt)

^b Tumor Marker Oncology Research Unit   (Egypt)

Author keywords

Granulocyte macrophage colony stimulating factor; Interleukin 6; Leukotriene B4; Pulmonary tuberculosis

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; LEUKOTRIENE B4;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0030941571     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329703400205     Document Type: Article

References (18)

1. Kien TE, Cammarate R. Laboratory diagnosis of mycobacterial infections in patients with acquired immunodeficiency syndrome. J Clin Microbiol 1986; 24: 708-11
2. Gasson JC. Molecular physiology of granulocyte-macrophage colony stimulating factor. Blood 1991; 77: 1131-45
3. Zhang Y, Broser M, Rom WN. Activation of the interleukin-6 gene by mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factor NF-IL-6 and NF-Kappa B. Proc Natl Acad Sci USA 1994; 591: 2225-9
4. Yokoyama A, Maruyama M, Ito M, Kohno N, Hiwada K, Yano S. Interleukin-6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity. Chest 1992; 102: 1055-9
5. Samuelsson B, Dahlen S-E, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis and biological effects. Science 1987; 237: 1171-6
6. Borgeat P, Samuelsson B. Arachidonic acid metabolism in polymorphonuclear leukocyte: Unstable intermediate in formation of dihydroxy acid. Proc Natl Acad Sci USA 1979; 76: 3213-7
7. 4 by human eosinophils. Clin Exp Immunol 1984; 56: 716-22
8. Peters SP, Macglashan DW, Schulman ES, Schleimer RP, Hayes EC, Rokach J, et al. Arachidonic acid metabolism in purified human lung mast cells. J Immunol 1984; 132: 1972-9
9. Warner JA, Peters SP, Lichtenstein LM, Hubbard W, Yancey KB, Stevenson HC, et al. Differential release of mediators from human basophils: Differences in arachidonic acid metabolism following activation by unrelated stimuli. J Leukoc Biol 1989; 45: 558-71
10. Kumlin M, Dahlen S-E. Characteristics of formation and further metabolism of leukotrienes in the chopped human lung. Biochem Biophys Acta 1990; 1044: 201-10
11. 4 in inflammation. Immunology 1990; 10: 1-12
12. 4 production by the human alveolar macrophage: A potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis 1984; 129: 106-11
13. Mansour M, Farouk N, El-Maragy A, Radwan I, El-Ahmady O. Elevated plasma level of leukotrienes in bronchial asthma patients: A possible clinical relevance. Dis Markers 1994; 12: 117-22
14. Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S. Increase in tumor necrosis factor alpha and interleukin-6 secreting cell in peripheral blood mononuclear cells from subjects infected with mycobacterium tuberculosis. Infect Immun 1991; 59: 3021-5
15. Tsukaguchi K, Yoneda T, Yoshikawa M, Tokuyama T, Fu A, Tomado K, et al. Case study of interleukin-l beta, tumor necrosis factor alpha and interleukin-6 production by peripheral blood monocytes in patients with diabetes mellitus complicated by pulmonary tuberculosis. Kekkaku 1992; 67: 755-60
16. 4 isomers. J Biol Chem 1987; 262: 10200-5
17. Mansour M, El-Kateib A, El-Ahmady O. Inhibited generation of leukotrienes from stimulated human leukocytes by the aqueous extract of propolis. Bull Fac Pharm Cairo Univ 1995; 33: 75-9
18. 4. Proc Natl Acad Sci USA 1983; 80: 1712-6